The oral semaglutide reduced the occurrence of major adverse cardiovascular events (MACE) by 14% in patients with type 2 ...

Former FDA Commissioner Dr. Scot Gottlieb joins 'Squawk Box' to discuss news of Novo Nordisk's oral diabetes drug cutting ...

The life sciences industry drives innovation, but environmental considerations must be incorporated from the beginning.

The conditions under which GenAI will be developed in Denmark were outlined in the government’s revised National Strategy for Digitalisation (NSD), published in February 2024. The NSD was backed by a ...

The American Heart Association and the American Stroke Association issued guidelines Monday that also look at the effects of testosterone and estrogen on the body. Meanwhile, Eli Lilly sues three ...